NASDAQ:OASM Investor Notice: Lawsuit Alleges Securities Laws Violations by Oasmia Pharmaceutical AB
An investor, who purchased shares of Oasmia Pharmaceutical AB (publ) (NASDAQ: OASM), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Oasmia Pharmaceutical AB in connection with certain allegedly false and misleading statements.
View full press release